Loading clinical trials...
Loading clinical trials...
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Conditions
Interventions
GNKG168
Locations
3
United States
Childrens Hospital Los Angeles
Los Angeles, California, United States
Johns Hopkins University
Baltimore, Maryland, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
March 26, 2014
Primary Completion Date
July 28, 2014
Completion Date
July 28, 2014
Last Updated
January 27, 2025
NCT02091245
NCT04012879
Lead Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions